Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain

计划入组 89 人 · 首次发布于 2022 年 3 月 18 日

Clinical Study of a Micro-Implantable Pulse Generator for the Treatment of Peripheral Neuropathic Pain (COMFORT 2)

计划入组 185 人 · 首次发布于 2023 年 5 月 23 日

Spinal Cord Stimulation in the Treatment of Chronic, Intractable Pain Using the Nalu™ Neurostimulation System

计划入组 110 人 · 首次发布于 2020 年 8 月 7 日

IPG

hATTR-PNS

IPG-1094

Nalu Medical, Inc.

United States

IPG Pharmaceuticals, Inc.

United States

MICRO LABS LIMITED

India

Nalu Reports 94% Response Rate in Largest Real-World Study of Peripheral Nerve Stimulation Device

Nalu Medical's COMFORT 2 Trial Establishes First Level-1 Evidence for Permanent Peripheral Nerve Stimulation in Chronic Pain

Boston Scientific to Acquire Nalu Medical for $533 Million, Expanding Peripheral Nerve Stimulation Portfolio